Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda (2019)
Attributed to:
Immunomodulation and Vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/aasopenres.12972.1
Publication URI: http://dx.doi.org/10.12688/aasopenres.12972.1
Type: Journal Article/Review
Parent Publication: AAS Open Research